title: Does treatment with antenatal glucocorticoids for the risk of premature delivery contribute to ketoacidosis in pregnant women with diabetes who receive continuous subcutaneous insulin infusion (CSII)?
authors.forename: B
authors.initials: B
authors.lastname: Bouhanick
authors.forename: F
authors.initials: F
authors.lastname: Biquard
authors.forename: S
authors.initials: S
authors.lastname: Hadjadj
authors.forename: M A
authors.initials: MA
authors.lastname: Roques
mesh_terms: D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000209:etiology*; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D007263:Infusions, Parenteral; D007328:Insulin / Q000008:administration & dosage*; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control; D015149:Tocolytic Agents / Q000627:therapeutic use
chemical_list: D005938:Glucocorticoids; D007328:Insulin; D015149:Tocolytic Agents